These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 30796300

  • 21. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
    Tatsumoto N, Yamada S, Tokumoto M, Eriguchi M, Noguchi H, Torisu K, Tsuruya K, Kitazono T.
    Am J Physiol Renal Physiol; 2015 Dec 01; 309(11):F967-79. PubMed ID: 26336165
    [Abstract] [Full Text] [Related]

  • 22. Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.
    Larivière R, Gauthier-Bastien A, Ung RV, St-Hilaire J, Mac-Way F, Richard DE, Agharazii M.
    J Hypertens; 2017 Feb 01; 35(2):376-384. PubMed ID: 28005706
    [Abstract] [Full Text] [Related]

  • 23. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.
    Chang JR, Guo J, Wang Y, Hou YL, Lu WW, Zhang JS, Yu YR, Xu MJ, Liu XY, Wang XJ, Guan YF, Zhu Y, Du J, Tang CS, Qi YF.
    Kidney Int; 2016 Mar 01; 89(3):586-600. PubMed ID: 26880455
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
    Liu L, Liu Y, Zhang Y, Bi X, Nie L, Liu C, Xiong J, He T, Xu X, Yu Y, Yang K, Gu J, Huang Y, Zhang J, Zhang Z, Zhang B, Zhao J.
    J Mol Cell Cardiol; 2018 Jan 01; 114():264-275. PubMed ID: 29197521
    [Abstract] [Full Text] [Related]

  • 28. Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease.
    Gauthier-Bastien A, Ung RV, Larivière R, Mac-Way F, Lebel M, Agharazii M.
    Clin Exp Hypertens; 2014 Jan 01; 36(3):173-80. PubMed ID: 23786435
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease.
    Yao L, Sun YT, Sun W, Xu TH, Ren C, Fan X, Sun L, Liu LL, Feng JM, Ma JF, Wang LN.
    Am J Nephrol; 2015 Jan 01; 41(1):28-36. PubMed ID: 25634106
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ginsenoside Rb1 ameliorates CKD-associated vascular calcification by inhibiting the Wnt/β-catenin pathway.
    Zhou P, Zhang X, Guo M, Guo R, Wang L, Zhang Z, Lin Z, Dong M, Dai H, Ji X, Lu H.
    J Cell Mol Med; 2019 Oct 01; 23(10):7088-7098. PubMed ID: 31423730
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.